speb/financial-data huggingface dataset:
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Investment Properties: 193430000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 5249000.00
NEULANDLAB.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 30994000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 107428000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 38475000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 742459000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 780934000.00
NEULANDLAB.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 30994000.00
NEULANDLAB.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -356237000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 102909000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 4634835000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Net Debt: 760940000.00
NEULANDLAB.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 80989000.00
NEULANDLAB.NS income_statement (annual, 2023-03-31) — Net Income: 1635176000.00
NEULANDLAB.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 1635176000.00
NEULANDLAB.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 1635176000.00
NEULANDLAB.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 1635176000.00
NEULANDLAB.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 1635176000.00
NEULANDLAB.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 2157464000.00
NEULANDLAB.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 1635176000.00
NEULANDLAB.NS income_statement (annual, 2023-03-31) — Net Interest Income: -115108000.00
NEULANDLAB.NS cash_flow (annual, 2023-03-31) — Net Investment Properties Purchase And Sale: 0.00
NEULANDLAB.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 15998000.00
NEULANDLAB.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -1135815000.00
NEULANDLAB.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -325243000.00
NEULANDLAB.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -115108000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Net PPE: 4998252000.00
NEULANDLAB.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -646372000.00
NEULANDLAB.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: -810572000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 7133348000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 582989000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 102909000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 98649000.00
NEULANDLAB.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 2761971000.00
NEULANDLAB.NS income_statement (annual, 2023-03-31) — Normalized Income: 1614498541.82
NEULANDLAB.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 2372119000.00
NEULANDLAB.NS income_statement (annual, 2023-03-31) — Operating Income: 2343414000.00
NEULANDLAB.NS income_statement (annual, 2023-03-31) — Operating Revenue: 11608985000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 12829889.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 537597000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 35587000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 9811960000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 13007000.00
NEULANDLAB.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 115108000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 39669000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 278000.00
NEULANDLAB.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 5204000.00
NEULANDLAB.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 271293000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Other Payable: 81194000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Other Properties: 4574322000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 100985000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 207171000.00
NEULANDLAB.NS income_statement (annual, 2023-03-31) — Other Special Charges: -27282000.00
NEULANDLAB.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Payables: 1896426000.00
NEULANDLAB.NS cash_flow (annual, 2023-03-31) — Pension And Employee Benefit Expense: -18746000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 175397000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 506900000.00
NEULANDLAB.NS income_statement (annual, 2023-03-31) — Pretax Income: 2157464000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
NEULANDLAB.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 46698000.00
NEULANDLAB.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment Properties: 0.00
NEULANDLAB.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -661285000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 976495000.00
NEULANDLAB.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 6137853000.00
NEULANDLAB.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 527774000.00
NEULANDLAB.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 8381000.00
NEULANDLAB.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 8381000.00
NEULANDLAB.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -1166809000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 136883000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 4652347000.00
NEULANDLAB.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 15998000.00
NEULANDLAB.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 14913000.00
NEULANDLAB.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 295793000.00
NEULANDLAB.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 594707000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Share Issued: 12829889.00
NEULANDLAB.NS cash_flow (annual, 2023-03-31) — Short Term Debt Payments: -810572000.00
NEULANDLAB.NS income_statement (annual, 2023-03-31) — Special Income Charges: 27282000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 9940965000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 7133348000.00
NEULANDLAB.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 6604541.82
NEULANDLAB.NS income_statement (annual, 2023-03-31) — Tax Provision: 522288000.00
NEULANDLAB.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.24
NEULANDLAB.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -436280000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Total Assets: 15797645000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 10683424000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Total Debt: 1284497000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 9940965000.00
NEULANDLAB.NS income_statement (annual, 2023-03-31) — Total Expenses: 9265571000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 5856680000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 8188704000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 1467110000.00
NEULANDLAB.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 26656000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 104019000.00
NEULANDLAB.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 27282000.00
NEULANDLAB.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 27282000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Work In Process: 1178888000.00
NEULANDLAB.NS balance_sheet (annual, 2023-03-31) — Working Capital: 3219371000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — +Operating Expense: 3744842000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — +Total Revenue: 15156631000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 1919591000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 3735262000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -2567676000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 4977735000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -6315000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Amortization: 10558000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 10558000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 12788000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 12829889.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Basic EPS: 233.89
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 454159000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 2170990000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -1436698000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 128826000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 129005000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 875754000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 1025854000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -128299000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 770600000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 105154000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -711885000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -191483000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: -100656000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Change In Payable: 203284000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -86629000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -907318000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 422081000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Common Stock: 129005000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Common Stock Dividend Paid: -128299000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 12827048000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 670730000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 7337967000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Current Assets: 9210807000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 36792000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Current Debt: 375864000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 412656000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 4276832000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 16359000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Depreciation: 586441000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 596999000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 596999000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 586441000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 12829889.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Diluted EPS: 233.89
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 3000789000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 1378000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — EBIT: 4125109000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — EBITDA: 4722108000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: -486000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — End Cash Position: 875754000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -692818000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 890305000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Fixed Assets Revaluation Reserve: 8389000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 1175069000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: 4016000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 309172000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Goodwill: 2794610000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 2819191000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 3741577000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 8465617000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Gross Profit: 7818664000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Interest Expense: 110744000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 110744000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Interest Income: 82268000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 82268000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -140549000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 78932000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Inventory: 3504219000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 13652118000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -1496868000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Investment Properties: 190276000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 12788000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 88219000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 287483000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 92034000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 449206000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 541240000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 88219000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -371046000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 76098000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 5336414000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -35471000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Net Income: 3000789000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 3000789000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 3000789000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 3000789000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 3000789000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 4014365000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 3000789000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Net Interest Income: -57706000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Net Investment Properties Purchase And Sale: 0.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -151734000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -394402000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: -282827000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -57706000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Net PPE: 5897941000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -1424066000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: -111575000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 10007857000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 604392000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 76098000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 91038000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 4723307000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Normalized Income: 3001685267.78
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 2611767000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Operating Income: 4073822000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Operating Revenue: 15156631000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 12829889.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 1168000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 49639000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 12698043000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 24581000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 57706000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 218184000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 125443000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 444555000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Other Payable: 76785000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Other Properties: 5227211000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 95093000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 150100000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Other Special Charges: 1199000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Payables: 1998568000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 466196000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 707111000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Pretax Income: 4014365000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: -2495000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -155101000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -1436698000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 1136940000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 7337967000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 596999000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 9202000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 9202000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -482621000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 142100000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 7524837000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 3367000.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Sale Of Investment Properties: 0.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 12632000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 219471000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 528643000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Share Issued: 12829889.00
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Short Term Debt Payments: -111575000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Special Income Charges: -1199000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 12827048000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 10007857000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: -302732.22
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Tax Provision: 1013576000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.25
NEULANDLAB.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -1116035000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Total Assets: 18325610000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 13276254000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Total Debt: 953896000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 12827048000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Total Expenses: 11082809000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 5498562000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 9114803000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 1221730000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 29230000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 814000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Total Unusual Items: -1199000.00
NEULANDLAB.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: -1199000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Treasury Shares Number: 0.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Work In Process: 1476974000.00
NEULANDLAB.NS balance_sheet (annual, 2024-03-31) — Working Capital: 4933975000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 2225520000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 3059304000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Assets Held For Sale Current: 139671000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 106662000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 153420000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 129005000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 724729000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 1975065000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 129005000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 13952122000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 1394214000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 9664787000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 46173000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 430588000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 476761000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 4131137000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 22843000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Goodwill: 2794610000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 2813760000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 6699862000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 3864554000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 14893585000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Investment Properties: 0.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 106662000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 107247000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 510875000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 618122000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 75966000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 216734000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 6699862000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 11138362000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 660657000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 12829889.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 626193000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 548307000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 13823117000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 19150000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 34220000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 5305648000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 1250336000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Payables: 2225708000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 12829889.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 13952122000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 11138362000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 19438004000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 14462997000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 1094883000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 13952122000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 5485882000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 9773217000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 1354745000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 188000.00
NEULANDLAB.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 5533650000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — +Operating Expense: 4172964000.00
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 1221876000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — +Total Revenue: 14343821000.00
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 3283600000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 2522036000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 2522036000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 3157206000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 3157206000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -2688995000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -2688995000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 4977735000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 4977735000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -23785000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -23785000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Amortization: 13239000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 13239000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 15289000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 15289000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 12829889.00
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 12831518.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Basic EPS: 202.74
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 21.67
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 875754000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 2541702000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 2541702000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -2064640000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 211275000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 211275000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 129005000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 129005000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 1319304000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1319304000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 3521831000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 3521831000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -179618000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 630500000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 630500000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 688804000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 688804000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -353350000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: 90056000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: -290599000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Change In Payable: 587567000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Change In Receivables: 549067000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: 577849000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 442093000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Common Stock: 129005000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 129005000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Common Stock Dividend Paid: -179618000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 15248063000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 15248063000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 596842000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 596842000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 7505080000.00
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1719904000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Current Assets: 11394969000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 11394969000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 25099000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 25099000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Current Debt: 452827000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 452827000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 477926000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 477926000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 4656859000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 4656859000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 20972000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 20972000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Depreciation: 642227000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 655466000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 655466000.00
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 168919000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 642227000.00
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 168919000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 12829889.00
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 12831518.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Diluted EPS: 202.74
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 21.67
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 2601081000.00
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 278059000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 1988000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 1988000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — EBIT: 3521184000.00
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — EBIT: 416463000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — EBITDA: 4176650000.00
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — EBITDA: 585382000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: 1457000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — End Cash Position: 1319304000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: 249610000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 685947000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 685947000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Fixed Assets Revaluation Reserve: 8389000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Fixed Assets Revaluation Reserve: 8389000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 1109402000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -840863000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 73106000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 372965000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Goodwill: 2794610000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Goodwill: 2794610000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 2843150000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 2843150000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 3180991000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 3180991000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 10022972000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 10022972000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Gross Profit: 6838741000.00
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 1563696000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Interest Expense: 57894000.00
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 23467000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 57894000.00
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 23467000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Interest Income: 105840000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 105840000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -83796000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 92905000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Inventory: 3857569000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 3857569000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 16608164000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 16608164000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -2981559000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Investment Properties: 0.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Investment Properties: 0.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 15289000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 15289000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 947782000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 330909000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 330909000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 186176000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 186176000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 907274000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 907274000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1093450000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1093450000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 947782000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -394353000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 72223000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 72223000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 6553519000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 6553519000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Net Debt: 40797000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 40797000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -1681000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Net Income: 2601081000.00
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Net Income: 278059000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 2601081000.00
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 278059000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 2601081000.00
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 278059000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 2601081000.00
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 278059000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 2601081000.00
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 278059000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 3463290000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 2601081000.00
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 278059000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Net Interest Income: 22869000.00
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -23467000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Net Investment Properties Purchase And Sale: 954313000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -1975779000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 553429000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 553429000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: 22869000.00
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -23467000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: -76000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Net PPE: 7333977000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 7333977000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -2052998000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: 0.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 12404913000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 12404913000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 728221000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 728221000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 72223000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 72223000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 98198000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 98198000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 3407963000.00
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 585382000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Normalized Income: 2023763723.47
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 278059000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 3174042000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Operating Income: 2665777000.00
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Operating Income: 341820000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Operating Revenue: 14343821000.00
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 3283600000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 12829889.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 12829889.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Other Cash Adjustment Outside Changein Cash: 214000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 693021000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 693021000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 63149000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 63149000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 15119058000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 15119058000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 48540000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 48540000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: -22869000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 155995000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 155995000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 205093000.00
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 74643000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 579046000.00
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 388382000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Other Payable: 81623000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 81623000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Other Properties: 6737135000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 6737135000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 84758000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 84758000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 2202527000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 2202527000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Other Special Charges: -691860000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Payables: 2606532000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Payables: 2606532000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 295755000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 295755000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 630419000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 630419000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Pretax Income: 3463290000.00
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 392996000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 17006000.00